IPO Boutique keeps apprised of the active pipeline. Currently there are 54 active IPOs in the pipeline as of July 21, 2017. No SPACs or Unit Offerings are included.
NEW FILINGS
Company: BJ Services, Inc.
Symbol: BJS
Description: They are the largest North American-focused, pure-play pressure pumping services provider.
Trade Date: TBD
Underwriter(s): Goldman Sachs & Co., Morgan Stanley, Credit Suisse
Filed: 7-14-17
Listed Cash Raise: $100 million
Company: Genprex, Inc.
Symbol: GNPX
Description: Genprex is a clinical stage gene therapy company developing a new approach to treating cancer, based upon their novel proprietary technology platform, including their initial product candidate, Oncoprex immunogene therapy, or Oncoprex.
Trade Date: TBD
Underwriter(s): Network 1 Financial Securities
Filed: 7-21-17
Listed Cash Raise: $22.5 million
Company: Nexpoint Multifamily Capital Trust
Symbol: NREF
Description: NREF will originate and structure preferred equity, alternative structured financing investments, mezzanine debt, bridge financing and first mortgage loans in properties benefiting from significant tenant diversification and short-term lease structures, including multifamily, storage and select-service and extended-stay hospitality properties.
Trade Date: TBD
Underwriter(s): TBD
Filed: 7-21-17
Listed Cash Raise: $10 million
TERMS ADDED
Company: Redfin Corporation
Symbol: RDFN
Description: Redfin is a technology-powered residential real estate brokerage.
Shares: 9.2 million
Price Range: $12.00-$14.00
Trade Date: 7/28
Underwriter(s): Goldman Sachs & Co., Allen & Company
Co-Manager: BofA Merrill Lynch, RBC Capital Markets, Oppenheimer & Co., Stifel
Filed: 7-17-17
Company: Sienna Biopharmaceuticals, Inc
Symbol: SNNA
Description: They are a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics
Shares: 4.3 million
Price Range: $14.00-$16.00
Trade Date: 7/27
Underwriter(s): J.P. Morgan, Cowen, BMO Capital Markets
Filed: 7-17-17
Company: Clementia Pharmaceuticals
Symbol: CMTA
Description: They are a clinical stage biopharmaceutical company that is developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need.
Shares: 7.15 million
Price Range: $13.00-$15.00
Trade Date: 8/2
Underwriter(s): Morgan Stanley, Leerink Partners
Co-Manager(s): Wedbush PacGrow, BTIG
Terms Added: 7-21-17
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish